Glenn Albrecht

Title: **Glenn Albrecht: Innovator in Nucleic Acid Research**

Introduction

Glenn Albrecht, an inventive mind based in Redwood City, California, has made significant contributions to the field of molecular biology and genetics. With a solid portfolio of twelve patents to his name, Albrecht has played a pivotal role in advancing methods for nucleic acid sequence identification and analysis. His innovative techniques provide valuable tools for research institutions and companies focusing on genetic expression and variation.

Latest Patents

Glenn Albrecht's latest patents demonstrate his expertise in developing sophisticated methodologies for nucleic acid analysis. One notable patent is titled "Method for determining relative abundance of nucleic acid sequences." This invention outlines methods for identifying nucleic acid sequences that vary in abundance across different source populations, such as differentially expressed genes or genomic variations among individuals. The method employs probes derived from the source nucleic acid populations, which are modified with a terminal sample ID sequence. This enables competitive hybridization with a reference nucleic acid library, enhancing the quantification of unhybridized SID sequences through fluorescent dye labeling and FACS sorting.

Another important patent pertains to "Solid phase selection of differentially expressed genes." This invention provides innovative methods and materials for monitoring and isolating differentially expressed genes using competitively hybridized labeled populations of DNAs with reference DNA on solid-phase supports like microparticles. This method allows for quantitative analysis of gene expression levels and identification of rare genes through fluorescence-activated cell sorting and subsequent sequencing.

Career Highlights

Throughout his career, Glenn Albrecht has been associated with several leading companies, including Lynx Therapeutics, Inc. His work at these institutions has significantly impacted the field of genomics and biotechnology, establishing him as a key figure in genetic research and innovation.

Collaborations

Albrecht has collaborated with renowned scientists, including Sydney Brenner and Robert B. Dubridge. These partnerships have further enriched his work and fostered advancements in genetic research, as he has combined his innovative ideas with the expertise of other prominent figures in the field.

Conclusion

Glenn Albrecht's contributions to nucleic acid research and his extensive patent portfolio highlight his role as a leading inventor in biotechnology. His innovative methodologies not only pave the way for future research but also enhance our understanding of genetic variations and expressions. As he continues to explore the intricacies of molecular biology, Albrecht remains a testament to the power of innovation and collaboration in science.